Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans arterial embolization of renal cell carcinoma

Anticancer Res. 1997 Mar-Apr;17(2B):1435-7.

Abstract

Background: Our aim was to determined the change of serum hepatocyte growth factorl scatter factor (HGF) before and after transarterial embolization (TAE) for renal cell carcinoma (RCC).

Materials and methods: We examined serum HGF levels in two patients.

Results: Serum HGF levels rapidly increased to six-fold higher levels immediately after heparin-injection even before embolization. Serum HGF then decreased to below 1.0 ng/ml at 6 hours after the procedure. The second peak (a two-fold increase) appeared 1-3 days after TACE. The first increase may have been due to the injection of heparin which releases HGF from the cell-surface and extracellular matrix. HGF is a pleiotropic cytokine which has a potential to enhance cell motility and angiogenesis related to tumor progression and the first larger elevation of serum HGF is enough to make a physiological effects.

Conclusion: Therefore, we should remind the physiological influence of heparin injection not only to prevent of clotting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / blood
  • Carcinoma, Renal Cell / therapy*
  • Embolization, Therapeutic*
  • Female
  • Heparin / pharmacology*
  • Hepatocyte Growth Factor / biosynthesis
  • Hepatocyte Growth Factor / blood*
  • Humans
  • Kidney Neoplasms / blood
  • Kidney Neoplasms / therapy*

Substances

  • Hepatocyte Growth Factor
  • Heparin